Creative Biolabs-Immuno-oncology

Anti-CD138 (clone IO6Z) SynExpress trc-Cy3-I4-E Modified CD8+ T cells (CAT#: ITS-1224-CR952)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD138 (clone IO6Z). We employs the AAV (trc-Cy3-IL-4-EcoRI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD138
Clone
IO6Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
trc
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
AAV
Transformation Accuracy
0.86
Cell Culture
Microcarrier Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.